Roche deal a platform to win new biz, Icon president says
Icon views its imaging deal with Roche as a “step towards breaking in with the [Swiss pharma]”, its president said.
Archives for March 8, 2012
Y-Prime aims to simplify clinical trial management with new confusion-free platform
Y-Prime Technologies has launched new clinical trial management software in a bid to answer what it says is an industry outcry for simpler tech.
Sanofi and Fresenius asked to take writedowns under Greek debt plan
The Greek government has asked several drugmakers to accept losses on bonds originally issued to cover unpaid bills.
GE to buy Xcellerex in latest biomanufacturing-focused investment
GE Healthcare has announced plans to buy US production tech firm Xcellerex, continuing its efforts to build its biomanufacturing offering.
inVentiv Health’s London comms office is open for business
The new inVentiv Health Communications Europe (iHCE) base – which officially opened last month – will serve as a marketing and support service hub or ‘super agency’ for the contract services firm’s revamped offering.
UPDATE
GSK and AstraZeneca fund NMR studies in a bid to improve manufacturing QC
GlaxoSmithKline (GSK) and Astrazeneca have each funded new nuclear magnetic resonance (NMR) research at the University of Warwick, UK which could improve the QC process for drugsmakers.
Pall’s Biopharma sales up in Q2
Filtration and processing tech firm Pall Life Sciences’ biopharmaceutical business made the biggest contribution to its revenues revenues in fiscal Q2.
BI builds contract biomanufacturing biz with €17m investment
Boehringer Ingelheim (BI) has expended its biomanufacturing offering in response to demand for early-phase development customers.